1113 related articles for article (PubMed ID: 14974922)
21. Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age.
Lagrou K; Froidecoeur C; Thomas M; Massa G; Beckers D; Craen M; de Beaufort C; Rooman R; François I; Heinrichs C; Lebrethon MC; Thiry-Counson G; Maes M; De Schepper J
Horm Res; 2008; 69(6):334-42. PubMed ID: 18504392
[TBL] [Abstract][Full Text] [Related]
22. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
de Kort SW; Willemsen RH; van der Kaay DC; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725
[TBL] [Abstract][Full Text] [Related]
23. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
24. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
Simon D; Léger J; Carel JC
Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291
[TBL] [Abstract][Full Text] [Related]
25. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
Ester W; Bannink E; van Dijk M; Willemsen R; van der Kaay D; de Ridder M; Hokken-Koelega A
Horm Res; 2008; 69(2):89-98. PubMed ID: 18059089
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
27. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
[TBL] [Abstract][Full Text] [Related]
28. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
Fjellestad-Paulsen A; Simon D; Czernichow P
J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
[TBL] [Abstract][Full Text] [Related]
29. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
30. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
31. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
de Zegher F; Albertsson-Wikland K; Wollmann HA; Chatelain P; Chaussain JL; Löfström A; Jonsson B; Rosenfeld RG
J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
[TBL] [Abstract][Full Text] [Related]
33. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
[TBL] [Abstract][Full Text] [Related]
35. Effect of different growth hormone dosages on the growth velocity in children born small for gestational age.
Bozzola E; Lauriola S; Messina MF; Bona G; Tinelli C; Tatò L
Horm Res; 2004; 61(2):98-102. PubMed ID: 14654718
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
[TBL] [Abstract][Full Text] [Related]
37. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
Aimaretti G; Corneli G; Rovere S; Croce CG; Ghigo E; Procopio M
J Endocrinol Invest; 2005; 28(10 Suppl):28-32. PubMed ID: 16550719
[TBL] [Abstract][Full Text] [Related]
38. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous growth hormone secretion and IGF1:IGFBP3 molar ratios in children born small for gestational age (SGA).
Völkl TM; Schwöbel K; Simm D; Beier C; Rohrer TR; Dörr HG
Growth Horm IGF Res; 2004 Dec; 14(6):455-61. PubMed ID: 15519254
[TBL] [Abstract][Full Text] [Related]
40. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
